With antimicrobial resistance (AMR) emerging as a silent pandemic, the veterinary sector faces escalating threats from drug-resistant fungal infections-and BioVenic is leading the charge.New York, USA - August 19, 2025 - The recent surge in antifungal drug resistance, as highlighted
Fighting Against Fungal Resistance: BioVenic Takes Charge in Veterinary AMR Innovation